Insider · CIK 0001670579

Haurwitz Rachel E.

Reports to the SEC for 3 companies · BERKELEY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001670579

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-20	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockA Award	Director, President and CEO	AAward	+683K sh	—	—	682,500
2026-02-20	CRBUCaribou Biosciences, Inc.A Award	Director, President and CEO	AAward	+152K sh	—	—	447,150
2025-03-14	CRBUCaribou Biosciences, Inc.P Purchase	Director, President and CEO	PPurchase	+20K sh	$1.02	+$20.4K	3,369,395
2025-02-20	CRBUCaribou Biosciences, Inc.A Award	Director, President and CEO	AAward	+137K sh	—	—	295,450
2025-02-20	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockA Award	Director, President and CEO	AAward	+618K sh	—	—	618,250
2024-06-12	SEERSeer, Inc.A Award	Director	AAward	+58.2K sh	—	—	87,615
2024-02-20	CRBUCaribou Biosciences, Inc.A Award	Director, President and CEO	AAward	+119K sh	—	—	158,700
2024-02-20	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockA Award	Director, President and CEO	AAward	+547K sh	—	—	546,950
2023-06-14	SEERSeer, Inc. · Stock Option (right to buy)A Award	Director	AAward	+34.7K sh	—	—	34,735
2023-06-14	SEERSeer, Inc.A Award	Director	AAward	+23.4K sh	—	—	29,437
2023-06-08	CRBUCaribou Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10K sh	$2.96	+$29.6K	40,000
2023-06-08	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10K sh	—	—	96,350
2023-03-20	CRBUCaribou Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10K sh	$2.96	+$29.6K	30,000
2023-03-20	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10K sh	—	—	106,350
2023-02-21	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockA Award	Director, President and CEO	AAward	+511K sh	—	—	510,500
2022-06-15	SEERSeer, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.9K sh	—	—	17,865
2022-06-15	SEERSeer, Inc.A Award	Director	AAward	+5,994 sh	—	—	5,994
2022-05-09	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10K sh	—	—	116,350
2022-05-09	CRBUCaribou Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10K sh	$2.96	+$29.6K	20,000
2022-01-26	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10K sh	—	—	126,350
2022-01-26	CRBUCaribou Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10K sh	$2.96	+$29.6K	10,000
2022-01-26	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10K sh	—	—	126,350
2022-01-26	CRBUCaribou Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10K sh	$2.96	+$29.6K	3,359,395
2021-12-20	CRBUCaribou Biosciences, Inc. · Option to purchase Common StockA Award	Director, President and CEO	AAward	+411K sh	—	—	411,000
2021-11-09	SEERSeer, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-09-27	CRBUCaribou Biosciences, Inc.G Gift	Director, President and CEO	GGift	+3.35M sh	—	—	3,349,395
2021-09-27	CRBUCaribou Biosciences, Inc.G Gift	Director, President and CEO	GGift	−3.35M sh	—	—	0
2016-05-11	NTLAIntellia Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+5.24M sh	—	—	5,593,846
2016-05-11	NTLAIntellia Therapeutics, Inc. · Founder StockC Conversion	Director, 10% Owner	CConversion	−270K sh	—	—	0
2016-05-11	NTLAIntellia Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+175K sh	—	—	349,612
2016-05-11	NTLAIntellia Therapeutics, Inc. · Junior Preferred StockC Conversion	Director, 10% Owner	CConversion	−8.11M sh	—	—	0
2016-05-05	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+23.5K sh	—	—	23,529

Recent filings

Accepted (ET)
Feb 204
Haurwitz Rachel E.0001670579-26-000002
SEC(opens sec.gov)
Mar 174
Haurwitz Rachel E.0001670579-25-000008
SEC(opens sec.gov)
Feb 214
Haurwitz Rachel E.0001670579-25-000003
SEC(opens sec.gov)
Jun 144
Haurwitz Rachel E.0001415889-24-016907
SEC(opens sec.gov)
Feb 224
Haurwitz Rachel E.0001628280-24-006421
SEC(opens sec.gov)
Jun 164
Haurwitz Rachel E.0001209191-23-038191
SEC(opens sec.gov)
Jun 94
Haurwitz Rachel E.0001619856-23-000073
SEC(opens sec.gov)
Mar 224
Haurwitz Rachel E.0001619856-23-000039
SEC(opens sec.gov)
Feb 234
Haurwitz Rachel E.0001619856-23-000028
SEC(opens sec.gov)
Jun 174
Haurwitz Rachel E.0001209191-22-038103
SEC(opens sec.gov)
May 104
Haurwitz Rachel E.0001209191-22-028170
SEC(opens sec.gov)
May 104/A
Haurwitz Rachel E.0001209191-22-028169
SEC(opens sec.gov)

Companies

Address

C/O CARIBOU BIOSCIENCES, INC. 2929 7TH STREET, SUITE 105

BERKELEY, CA, 94710